ZEB2 and acute lymphoblastic leukemia: These data are strongly indicative for an oncogenic driver role for ZEB2 in T-ALL, and is consistent with previously reported retroviral mutagenesis screens28, 29, 30 that have suggested Zeb2 involvement in leukaemogenesis.